Update Results Of Anlotinib Combined With Tqb2450 (Pd-L1 Blockade) As First-Line Treatment For Advanced Esophageal Squamous Cell Carcinoma (Escc): A Single-Arm, Multicenter, Open-Label Phase II Clinical Trial
Anlotinib;TQB-2450
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Update Results Of Anlotinib Combined With Tqb2450 (Pd-L1 Blockade) As First-Line Treatment For Advanced Esophageal Squamous Cell Carcinoma (Escc): A Single-Arm, Multicenter, Open-Label Phase II Clinical Trial ### Output: Anlotinib;TQB-2450